Close

Predictive Oncology Inc. (POAI) Announces J. Melville Engle as CEO

Go back to Predictive Oncology Inc. (POAI) Announces J. Melville Engle as CEO

Predictive Oncology Inc. Announces New CEO

March 23, 2021 8:30 AM EDT

MINNEAPOLIS, March 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, is excited to announce today that they have appointed J. Melville (Mel) Engle as Chief Executive Officer of the company.

In addition to being named CEO, Mr. Engle will retain his role of Chairman of the Board. Mr. Engle joined POAIs Board of Directors in October, 2016 and was appointed Chairman of the Board in January, 2020.

Mr. Engle has over 20 years experience in leadership roles in both the... More